Kybella Approval History
FDA Approved: Yes (First approved April 29, 2015)
Brand name: Kybella
Generic name: deoxycholic acid
Dosage form: Injection
Previous Name: ATX-101
Company: Allergan plc
Treatment for: Submental Fullness
Kybella (deoxycholic acid) is a cytolytic drug indicated to improve the appearance of fullness associated with submental fat (double chin).
Development History and FDA Approval Process for Kybella
|Apr 29, 2015||FDA Approves Kybella (deoxycholic acid) to Treat Submental Fullness, or 'Double Chin'|
|Mar 9, 2015||Kythera Biopharmaceuticals Announces FDA Advisory Committee Unanimously Recommends to Approve ATX-101|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.